Washington, DC: Drug and Alcohol Rehabilitation Center Southern California

Washington, DC: Drug and Alcohol Rehabilitation Center Southern California – Laguna Beach Recovery Center www.Lagunarecovery.com (866)491-0214 Laguna Beach Recovery Center is based on a loving dignified approach, in renowned Laguna Beach, California. As an Alcohol and drug treatment recovery facility we have the highest long-term success rate in the industry, and will treat you or your loved one like family. We have a highly effective therapeutic approach to treating alcohol and drug addiction. Our renowned treatment is coupled with our finely appointed amenities that are steps from the beach. We focus on providing the foundation and tools for lifelong recovery. Each program is designed and based upon an individuals specific needs. We have a wide variety of programs including 3-5 day detox, 7-10 day fast track, core 30 day programs, extended care, transitional living, as well as executive and professional treatment options.

O'Rourke Leads Carrasco for District 16 Rep

Filed under: drug treatment programs washington dc

In less than a week, El Paso will decide whether it'll be Beto O'Rourke or Barbara Carrasco headed to Washington D.C. to represent District 16. But once there … "So that we're not sending veterans to Albuquerque, New Mexico for treatment, or to Big …
Read more on KTSM News Channel 9

Marijuana's Recreational, Medical Use on Ballots in Six States

Filed under: drug treatment programs washington dc

Marijuana advocates have placed measures on ballots in six states dealing with the recreational or medical use of the drug, defying federal efforts to crack down on use where it's already legal. … “There would be some signal there to Washington, D.C …
Read more on Businessweek

Boehringer Ingelheim to Pay Million to Resolve False Claims Act Allegations

Filed under: drug treatment programs washington dc

Washington, DC – Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $ 95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD …
Read more on Yumanewsnow